SCHEMBL7983648

SCHEMBL7983648

Cc1cccc(Cl)c1-c1ncc2c(N)nc3ccc(NCCN4CCOCC4)cc3n12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 5/20 0.57
MAP3K8 P41279 1/20 0.43
DHFR P00374 1/20 0.42
PDE2A O00408 3/20 0.42
PDPK1 O15530 1/20 0.42
FGFR1 P11362 4/20 0.41
SRC P12931 3/20 0.41
HSD17B10 Q99714 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TSHR P16473 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
CASP1 P29466 1/20 0.40
FGFR2 P21802 1/20 0.40
FGFR4 P22455 1/20 0.40
FGFR3 P22607 1/20 0.40
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983209 0.95 LCK (0.58) LCKPDE2AFGFR1SRCHSD17B10
SCHEMBL7983613 0.93 LCK (0.51) LCKMAP3K8DHFRPDE2AFGFR1
SCHEMBL7980015 0.88 LCK (0.52) LCKMAP3K8PDE2AFGFR1SRC
SCHEMBL4041225 0.87 FGFR1 (0.51) LCKMAP3K8PDPK1FGFR1SRC
SCHEMBL7983062 0.83 LCK (0.50) LCKPDE2AFGFR1KDR
SCHEMBL7979955 0.83 LCK (0.54) LCKPDE2AFGFR1KDR
SCHEMBL7980189 0.82 CAMK2D (0.44) LCKFGFR1KDR
SCHEMBL7970474 0.81 LCK (0.39) LCKPDE2AFGFR1KDR
SCHEMBL7983672 0.80 FGFR1 (0.53) LCKMAP3K8FGFR1SRCFGFR2
SCHEMBL7982210 0.80 MAP3K8 (0.42) LCKMAP3K8FGFR1SRCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed